Clinical Trial Update: A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the safety and efficacy of BOTOX (onabotulinumtoxinA) in adults with moderate COPD; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: RMW Testing | Conditions: COPD | Phase 2 | Status: COMPLETED